Depletion of BRN2 from melanoma cells has consistently been described to reduce MITF levels (Cook et al., 2005; Thomson et al., 1995; Thurber et al., 2011; Wellbrock et al., 2008), indicating that BRN2 is required to drive MITF expression. The gene discussed is POU3F2; the disease is melanoma.